[Large health benefits can be achieved by better treatment of gout]

Area of Science:

• Rheumatology
• Pharmacology

Background:

• Recent guidelines recommend initiating urate-lowering therapy (ULT) after the first gout attack.
• Allopurinol is the primary first-line ULT, requiring dose titration to achieve target blood urate levels.

Purpose of the Study:

• To summarize current recommendations for gout management and urate-lowering therapy.
• To emphasize the importance of patient education and follow-up in ULT.

Main Methods:

• Review of recent guidelines and randomized controlled trials (RCTs) on ULT.
• Analysis of treatment targets and management strategies for gout attacks.

Main Results:

• ULT should be initiated early, with dose adjustments to reach blood urate targets (< 360 µmol/l or < 300 µmol/l with tophi).
• Short-term treatments for gout attacks include NSAIDs, colchicine, and glucocorticoids.
• ULT should continue during gout attacks, and can be initiated during an adequately treated attack.

Conclusions:

• Effective gout management requires early ULT initiation and dose titration to target urate levels.
• Patient education and regular follow-up significantly improve compliance and outcomes for ULT.
• Short-term anti-inflammatory treatments are essential for managing acute gout flares.